Diabetes 52:2935-2942, 2003
© 2003 by the American Diabetes Association, Inc.
Brain Death Significantly Reduces Isolated Pancreatic Islet Yields and Functionality In Vitro and In Vivo After Transplantation in Rats
Juan L. Contreras1,
Christopher Eckstein1,
Cheryl A. Smyth1,
Marty T. Sellers2,
Mario Vilatoba1,
Guadalupe Bilbao1,
Firoz G. Rahemtulla3,
Carlton J. Young1,
J. Anthony Thompson1,
Irshad H. Chaudry4, and
Devin E. Eckhoff1
1 Division of Transplantation, University of Alabama at Birmingham, Birmingham, Alabama
2 Division of Transplantation, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
3 Department of Prosthodontics and Biomaterials, University of Alabama School of Dentistry, University of Alabama at Birmingham, Birmingham, Alabama
4 Center for Surgical Research, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
Although 1 million islets exist in the adult human pancreas, current pancreas preservation and islet isolation techniques recover <50%. Presently, cadaveric donors remain the sole source of pancreatic tissue for transplantation. Brain death is characterized by activation of proinflammatory cytokines and organ injury during preservation and reperfusion. In this study, we assessed the effects of brain death on islet isolation yields and functionality. Brain death was induced in male 250- to 350-g Lewis rats by inflation of a Fogarty catheter placed intracranially. The rats were mechanically ventilated for 2, 4, and 6 h before removal of the pancreas (n = 6). In controls, the catheter was not inflated (n = 6). Shortly after brain death induction, a significant increase in serum tumor necrosis factor- (TNF- ), interleukin (IL)-1ß, and IL-6 was demonstrated in a time-dependent manner. Upregulation of TNF- , IL-1ß, and IL-6 mRNA was noted in the pancreas. Brain death donors presented lower insulin release after glucose stimulation assessed by in situ perfusion of the pancreas. Islet recovery was reduced in brain death donors compared with controls (at 6 h 602.3 ± 233.4 vs. 1,792.5 ± 325.4 islet equivalents, respectively; P < 0.05). Islet viability assessed in dissociated islet cells and in intact cultured islets was reduced in islets recovered from brain death donors, an effect associated with higher nuclear activities of NF- B p50, c-Jun, and ATF-2. Islet functionality evaluated in vitro by static incubation and in vivo after intraportal transplantation in syngeneic streptozotocin-induced diabetic rats was significantly reduced in preparations obtained from brain death donors. In conclusion, brain death significantly reduced islet yields and functionality. These observations may lead to strategies to reduce the effects of brain death on pancreatic islets and improve the results in clinical transplantation.
Address correspondence and reprint requests to Juan L. Contreras, 748 Lyons-Harrison Research Building, 701 19th Street South, Birmingham, AL 35294-0007. E-mail: juan.contreras{at}ccc.uab.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Cabric, J. Sanchez, T. Lundgren, A. Foss, M. Felldin, R. Kallen, K. Salmela, A. Tibell, G. Tufveson, R. Larsson, et al.
Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet Transplantation
Diabetes,
August 1, 2007;
56(8):
2008 - 2015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bertuzzi and C. Ricordi
Prediction of Clinical Outcome in Islet Allotransplantation
Diabetes Care,
February 1, 2007;
30(2):
410 - 417.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, S. S. Lee, W. Gao, E. Czismadia, J. McDaid, R. Ollinger, M. P. Soares, K. Yamashita, and F. H. Bach
Donor Treatment With Carbon Monoxide Can Yield Islet Allograft Survival and Tolerance
Diabetes,
May 1, 2005;
54(5):
1400 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schroppel, N. Zhang, P. Chen, D. Chen, J. S. Bromberg, and B. Murphy
Role of Donor-Derived Monocyte Chemoattractant Protein-1 in Murine Islet Transplantation
J. Am. Soc. Nephrol.,
February 1, 2005;
16(2):
444 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Contreras, C. Eckstein, C. A. Smyth, G. Bilbao, M. Vilatoba, S. E. Ringland, C. Young, J. A. Thompson, J. A. Fernandez, J. H. Griffin, et al.
Activated Protein C Preserves Functional Islet Mass After Intraportal Transplantation: A Novel Link Between Endothelial Cell Activation, Thrombosis, Inflammation, and Islet Cell Death
Diabetes,
November 1, 2004;
53(11):
2804 - 2814.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|